Drug firm AstraZeneca sees 3rd quarter earnings fall 12 pct

LONDON (AP) — Anglo-Swedish drugmaker AstraZeneca said Thursday that its third-quarter earnings fell 12 percent as its blockbuster cholesterol drug Crestor faced its first full quarter of competition in the United States from generic alternatives.